世界の潰瘍性大腸炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ulcerative Colitis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5784
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、126ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、潰瘍性大腸炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、免疫系サプレッサー、その他薬）、用途別市場規模（病院、クリニック、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・潰瘍性大腸炎治療の市場動向
・企業の競争状況、市場シェア
・潰瘍性大腸炎治療の種類別市場規模（抗炎症薬、免疫系サプレッサー、その他薬）
・潰瘍性大腸炎治療の用途別市場規模（病院、クリニック、ドラッグストア、その他）
・潰瘍性大腸炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・潰瘍性大腸炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・潰瘍性大腸炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・潰瘍性大腸炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・潰瘍性大腸炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、Roche、Sanofi、GSK、AstraZeneca、MSD、Johnson & Johnson、Bayer、AbbVie、Eli Lilly and Company、Amgen、Takeda Pharmaceuticals Company、Ferring Pharmaceuticals、InDeX Pharmaceuticals）
・結論

Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).

Market Analysis and Insights: Global Ulcerative Colitis Treatment Market
The global Ulcerative Colitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ulcerative Colitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ulcerative Colitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ulcerative Colitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ulcerative Colitis Treatment market.

Global Ulcerative Colitis Treatment Scope and Market Size
Ulcerative Colitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ulcerative Colitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-inflammatory Drugs
Immune System Suppressors
Other medications

Segment by Application
Hospital
Clinic
Drugs Store
Others

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Roche
Sanofi
GSK
AstraZeneca
MSD
Johnson & Johnson
Bayer
Sanofi
GSK
Amgen
Takeda Pharmaceuticals Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ulcerative Colitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory Drugs
1.2.3 Immune System Suppressors
1.2.4 Other medications
1.3 Market by Application
1.3.1 Global Ulcerative Colitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugs Store
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ulcerative Colitis Treatment Market Perspective (2016-2027)
2.2 Ulcerative Colitis Treatment Growth Trends by Regions
2.2.1 Ulcerative Colitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ulcerative Colitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Ulcerative Colitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Ulcerative Colitis Treatment Industry Dynamic
2.3.1 Ulcerative Colitis Treatment Market Trends
2.3.2 Ulcerative Colitis Treatment Market Drivers
2.3.3 Ulcerative Colitis Treatment Market Challenges
2.3.4 Ulcerative Colitis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ulcerative Colitis Treatment Players by Revenue
3.1.1 Global Top Ulcerative Colitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Ulcerative Colitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Ulcerative Colitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ulcerative Colitis Treatment Revenue
3.4 Global Ulcerative Colitis Treatment Market Concentration Ratio
3.4.1 Global Ulcerative Colitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Treatment Revenue in 2020
3.5 Ulcerative Colitis Treatment Key Players Head office and Area Served
3.6 Key Players Ulcerative Colitis Treatment Product Solution and Service
3.7 Date of Enter into Ulcerative Colitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ulcerative Colitis Treatment Breakdown Data by Type
4.1 Global Ulcerative Colitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Ulcerative Colitis Treatment Forecasted Market Size by Type (2022-2027)

5 Ulcerative Colitis Treatment Breakdown Data by Application
5.1 Global Ulcerative Colitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Ulcerative Colitis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ulcerative Colitis Treatment Market Size (2016-2027)
6.2 North America Ulcerative Colitis Treatment Market Size by Type
6.2.1 North America Ulcerative Colitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Ulcerative Colitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Ulcerative Colitis Treatment Market Size by Type (2016-2027)
6.3 North America Ulcerative Colitis Treatment Market Size by Application
6.3.1 North America Ulcerative Colitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Ulcerative Colitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Ulcerative Colitis Treatment Market Size by Application (2016-2027)
6.4 North America Ulcerative Colitis Treatment Market Size by Country
6.4.1 North America Ulcerative Colitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Ulcerative Colitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ulcerative Colitis Treatment Market Size (2016-2027)
7.2 Europe Ulcerative Colitis Treatment Market Size by Type
7.2.1 Europe Ulcerative Colitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Ulcerative Colitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Ulcerative Colitis Treatment Market Size by Type (2016-2027)
7.3 Europe Ulcerative Colitis Treatment Market Size by Application
7.3.1 Europe Ulcerative Colitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Ulcerative Colitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Ulcerative Colitis Treatment Market Size by Application (2016-2027)
7.4 Europe Ulcerative Colitis Treatment Market Size by Country
7.4.1 Europe Ulcerative Colitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Ulcerative Colitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ulcerative Colitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Ulcerative Colitis Treatment Market Size by Type
8.2.1 Asia-Pacific Ulcerative Colitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ulcerative Colitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ulcerative Colitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Ulcerative Colitis Treatment Market Size by Application
8.3.1 Asia-Pacific Ulcerative Colitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ulcerative Colitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ulcerative Colitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Ulcerative Colitis Treatment Market Size by Region
8.4.1 Asia-Pacific Ulcerative Colitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ulcerative Colitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ulcerative Colitis Treatment Market Size (2016-2027)
9.2 Latin America Ulcerative Colitis Treatment Market Size by Type
9.2.1 Latin America Ulcerative Colitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Ulcerative Colitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Ulcerative Colitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Ulcerative Colitis Treatment Market Size by Application
9.3.1 Latin America Ulcerative Colitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Ulcerative Colitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Ulcerative Colitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Ulcerative Colitis Treatment Market Size by Country
9.4.1 Latin America Ulcerative Colitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Ulcerative Colitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ulcerative Colitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Ulcerative Colitis Treatment Market Size by Type
10.2.1 Middle East & Africa Ulcerative Colitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ulcerative Colitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ulcerative Colitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Ulcerative Colitis Treatment Market Size by Application
10.3.1 Middle East & Africa Ulcerative Colitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ulcerative Colitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ulcerative Colitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Ulcerative Colitis Treatment Market Size by Country
10.4.1 Middle East & Africa Ulcerative Colitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ulcerative Colitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Ulcerative Colitis Treatment Introduction
11.1.4 Pfizer Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Ulcerative Colitis Treatment Introduction
11.2.4 Novartis Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Ulcerative Colitis Treatment Introduction
11.3.4 Roche Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Ulcerative Colitis Treatment Introduction
11.4.4 Sanofi Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Ulcerative Colitis Treatment Introduction
11.5.4 GSK Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.5.5 GSK Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Ulcerative Colitis Treatment Introduction
11.6.4 AstraZeneca Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 MSD
11.7.1 MSD Company Details
11.7.2 MSD Business Overview
11.7.3 MSD Ulcerative Colitis Treatment Introduction
11.7.4 MSD Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.7.5 MSD Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Ulcerative Colitis Treatment Introduction
11.8.4 Johnson & Johnson Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Ulcerative Colitis Treatment Introduction
11.9.4 Bayer Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Ulcerative Colitis Treatment Introduction
11.10.4 AbbVie Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.10.5 AbbVie Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Ulcerative Colitis Treatment Introduction
11.11.4 Eli Lilly and Company Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.11.5 Eli Lilly and Company Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Ulcerative Colitis Treatment Introduction
11.12.4 Amgen Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Takeda Pharmaceuticals Company
11.13.1 Takeda Pharmaceuticals Company Company Details
11.13.2 Takeda Pharmaceuticals Company Business Overview
11.13.3 Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Introduction
11.13.4 Takeda Pharmaceuticals Company Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.13.5 Takeda Pharmaceuticals Company Recent Development
11.14 Ferring Pharmaceuticals
11.14.1 Ferring Pharmaceuticals Company Details
11.14.2 Ferring Pharmaceuticals Business Overview
11.14.3 Ferring Pharmaceuticals Ulcerative Colitis Treatment Introduction
11.14.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.14.5 Ferring Pharmaceuticals Recent Development
11.15 InDeX Pharmaceuticals
11.15.1 InDeX Pharmaceuticals Company Details
11.15.2 InDeX Pharmaceuticals Business Overview
11.15.3 InDeX Pharmaceuticals Ulcerative Colitis Treatment Introduction
11.15.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Treatment Business (2016-2021)
11.15.5 InDeX Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ulcerative Colitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory Drugs
Table 3. Key Players of Immune System Suppressors
Table 4. Key Players of Other medications
Table 5. Global Ulcerative Colitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ulcerative Colitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ulcerative Colitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Ulcerative Colitis Treatment Market Share by Regions (2016-2021)
Table 9. Global Ulcerative Colitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Ulcerative Colitis Treatment Market Share by Regions (2022-2027)
Table 11. Ulcerative Colitis Treatment Market Trends
Table 12. Ulcerative Colitis Treatment Market Drivers
Table 13. Ulcerative Colitis Treatment Market Challenges
Table 14. Ulcerative Colitis Treatment Market Restraints
Table 15. Global Ulcerative Colitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Ulcerative Colitis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Ulcerative Colitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis Treatment as of 2020)
Table 18. Ranking of Global Top Ulcerative Colitis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Ulcerative Colitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ulcerative Colitis Treatment Product Solution and Service
Table 22. Date of Enter into Ulcerative Colitis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ulcerative Colitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Ulcerative Colitis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Ulcerative Colitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Ulcerative Colitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Ulcerative Colitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Ulcerative Colitis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Ulcerative Colitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Ulcerative Colitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Ulcerative Colitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Ulcerative Colitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Ulcerative Colitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Ulcerative Colitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Ulcerative Colitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Ulcerative Colitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Ulcerative Colitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Ulcerative Colitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Ulcerative Colitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Ulcerative Colitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Ulcerative Colitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Ulcerative Colitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Ulcerative Colitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Ulcerative Colitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ulcerative Colitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ulcerative Colitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ulcerative Colitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Ulcerative Colitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Ulcerative Colitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Ulcerative Colitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Ulcerative Colitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Ulcerative Colitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Ulcerative Colitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Ulcerative Colitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Ulcerative Colitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Ulcerative Colitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ulcerative Colitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ulcerative Colitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ulcerative Colitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Ulcerative Colitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Ulcerative Colitis Treatment Product
Table 65. Pfizer Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Ulcerative Colitis Treatment Product
Table 70. Novartis Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Ulcerative Colitis Treatment Product
Table 75. Roche Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Ulcerative Colitis Treatment Product
Table 80. Sanofi Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. GSK Company Details
Table 83. GSK Business Overview
Table 84. GSK Ulcerative Colitis Treatment Product
Table 85. GSK Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 86. GSK Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Ulcerative Colitis Treatment Product
Table 90. AstraZeneca Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. MSD Company Details
Table 93. MSD Business Overview
Table 94. MSD Ulcerative Colitis Treatment Product
Table 95. MSD Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 96. MSD Recent Development
Table 97. Johnson & Johnson Company Details
Table 98. Johnson & Johnson Business Overview
Table 99. Johnson & Johnson Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 100. Johnson & Johnson Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Ulcerative Colitis Treatment Product
Table 104. Bayer Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 105. Bayer Recent Development
Table 106. AbbVie Company Details
Table 107. AbbVie Business Overview
Table 108. AbbVie Ulcerative Colitis Treatment Product
Table 109. AbbVie Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 110. AbbVie Recent Development
Table 111. Eli Lilly and Company Company Details
Table 112. Eli Lilly and Company Business Overview
Table 113. Eli Lilly and Company Ulcerative Colitis Treatment Product
Table 114. Eli Lilly and Company Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 115. Eli Lilly and Company Recent Development
Table 116. Amgen Company Details
Table 117. Amgen Business Overview
Table 118. Amgen Ulcerative Colitis Treatment Product
Table 119. Amgen Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 120. Amgen Recent Development
Table 121. Takeda Pharmaceuticals Company Company Details
Table 122. Takeda Pharmaceuticals Company Business Overview
Table 123. Takeda Pharmaceuticals Company Ulcerative Colitis Treatment Product
Table 124. Takeda Pharmaceuticals Company Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 125. Takeda Pharmaceuticals Company Recent Development
Table 126. Ferring Pharmaceuticals Company Details
Table 127. Ferring Pharmaceuticals Business Overview
Table 128. Ferring Pharmaceuticals Ulcerative Colitis Treatment Product
Table 129. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 130. Ferring Pharmaceuticals Recent Development
Table 131. InDeX Pharmaceuticals Company Details
Table 132. InDeX Pharmaceuticals Business Overview
Table 133. InDeX Pharmaceuticals Ulcerative Colitis Treatment Product
Table 134. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Treatment Business (2016-2021) & (US$ Million)
Table 135. InDeX Pharmaceuticals Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ulcerative Colitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory Drugs Features
Figure 3. Immune System Suppressors Features
Figure 4. Other medications Features
Figure 5. Global Ulcerative Colitis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Drugs Store Case Studies
Figure 9. Others Case Studies
Figure 10. Ulcerative Colitis Treatment Report Years Considered
Figure 11. Global Ulcerative Colitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Ulcerative Colitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ulcerative Colitis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Ulcerative Colitis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Ulcerative Colitis Treatment Market Share by Players in 2020
Figure 16. Global Top Ulcerative Colitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Ulcerative Colitis Treatment Revenue in 2020
Figure 18. Global Ulcerative Colitis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Ulcerative Colitis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Ulcerative Colitis Treatment Market Share by Type (2016-2027)
Figure 22. North America Ulcerative Colitis Treatment Market Share by Application (2016-2027)
Figure 23. North America Ulcerative Colitis Treatment Market Share by Country (2016-2027)
Figure 24. United States Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ulcerative Colitis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Ulcerative Colitis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Ulcerative Colitis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ulcerative Colitis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Ulcerative Colitis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Ulcerative Colitis Treatment Market Share by Region (2016-2027)
Figure 40. China Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ulcerative Colitis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Ulcerative Colitis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Ulcerative Colitis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ulcerative Colitis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Ulcerative Colitis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Ulcerative Colitis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Ulcerative Colitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 65. MSD Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 67. Bayer Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 68. AbbVie Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 69. Eli Lilly and Company Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 70. Amgen Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 71. Takeda Pharmaceuticals Company Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 72. Ferring Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 73. InDeX Pharmaceuticals Revenue Growth Rate in Ulcerative Colitis Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界の潰瘍性大腸炎市場規模・現状・予測（2021年-2027年）

Global Ulcerative Colitis Market Size, Status and Forecast 2021-2027
QYR2104Z5783 2021年4月 96Pages
QYResearch社発行の本調査資料では、潰瘍性大腸炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南...

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界のジフテリア治療市場規模・現状・予測（2021年-2027年）

Global Diphtheria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1902 2021年4月 95Pages
QYResearch社発行の本調査資料では、ジフテリア治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）、用途別市場規模（抗毒素、抗生物質、その他）、主...

世界の水疱性類天疱瘡治療市場規模・現状・予測（2021年-2027年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1030 2021年4月 97Pages
QYResearch社発行の本調査資料では、水疱性類天疱瘡治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）、用途別市場規模（病院薬局、小売薬局、通信販売薬局）、主要地域別市場規模（北米、アメ...

世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4022 2021年4月 94Pages
QYResearch社発行の本調査資料では、ナルコレプシー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の軟骨肉腫治療市場規模・現状・予測（2021年-2027年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1305 2021年4月 99Pages
QYResearch社発行の本調査資料では、軟骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、化学療法、放射線療法）、用途別市場規模（病院、専門クリニック、がん治療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の裂肛治療市場規模・現状・予測（2021年-2027年）

Global Anal Fissure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0309 2021年4月 91Pages
QYResearch社発行の本調査資料では、裂肛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所ニトログリセリン、カルシウムチャネル遮断薬、便軟化剤、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリ...

世界の早産治療市場規模・現状・予測（2021年-2027年）

Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4769 2021年4月 93Pages
QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界のハンセン病治療市場規模・現状・予測（2021年-2027年）

Global Leprosy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3400 2021年4月 91Pages
QYResearch社発行の本調査資料では、ハンセン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホン、フェナジン誘導体、抗管状薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の潰瘍性大腸炎市場規模・現状・予測（2021年-2027年） Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum). Market Analysis…
世界の免疫性炎症性疾患治療市場規模・現状・予測（2021年-2027年） Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune respon…
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
世界の炎症性腸疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
世界の眼瞼炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blepharitis Treatment Drugs Market The global Blepharitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…